Thus, to investigate whether NRF2 repression would also lead to depletion of total cellular GSH, the panel of ovarian cancer cells (PEO1, OVCAR3, and SKOV3) was treated in the same manner as the AREc32 cells (Figure 8(a)) for 96 h. This evidence concerns the gene NFE2L2 and ovarian carcinoma.